InvestorsHub Logo
Followers 68
Posts 1339
Boards Moderated 0
Alias Born 08/12/2014

Re: None

Monday, 05/02/2016 5:48:46 PM

Monday, May 02, 2016 5:48:46 PM

Post# of 725925
That's a good question. One thing for certain is that LP now has to be operating under the sun, which is a big plus. Those many millions of shares issued to Cognate have to be reduced in value either by hiking the price per piece or cutting the total numbers, which is good for retail investors either way!

One other way forward is to use the balance of the aggregate issuance in question as future payment!

I am glad to hearing today's news, particularly this only negative part of all good news, because it signals changes are coming in the positive way.

The update on P2 D trials with three different sets of leading parties in three different cancer indications are all good. My hope is NWBO will still get a fair good of deals with other parties under the current difficult situations.

As far as L-trial is concerned, it certainly is assuring, and the issue will be resolved soon. After that, I bet the final data will come quickly with FDA decision.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News